-
Signature
-
/s/ Larissa Schwartz, attorney-in-fact of the Reporting Person
-
Issuer symbol
-
OKTA
-
Transactions as of
-
13 Jan 2026
-
Net transactions value
-
-$99,940
-
Form type
-
4
-
Filing time
-
15 Jan 2026, 17:17:53 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Ninan Shibu |
Chief Accounting Officer |
100 FIRST STREET, SUITE 600, SAN FRANCISCO |
/s/ Larissa Schwartz, attorney-in-fact of the Reporting Person |
15 Jan 2026 |
0001940985 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
OKTA |
Class A Common Stock |
Sale |
$99,940 |
-1,052 |
-5.7% |
$95.00 |
17,468 |
13 Jan 2026 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| holding |
OKTA |
Restricted Stock Units |
|
|
|
|
|
6,588 |
13 Jan 2026 |
Class A Common Stock |
6,588 |
|
Direct |
F3, F4 |
| holding |
OKTA |
Restricted Stock Units |
|
|
|
|
|
556 |
13 Jan 2026 |
Class A Common Stock |
556 |
|
Direct |
F3, F5 |
| holding |
OKTA |
Restricted Stock Units |
|
|
|
|
|
2,421 |
13 Jan 2026 |
Class A Common Stock |
2,421 |
|
Direct |
F3, F6 |
| holding |
OKTA |
Restricted Stock Units |
|
|
|
|
|
7,524 |
13 Jan 2026 |
Class A Common Stock |
7,524 |
|
Direct |
F3, F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: